Remote Neurobased Approach to Aphasia Therapy (RNAAT)
Primary Purpose
Aphasia, Broca, Aphasia, Wernicke, Aphasia, Fluent
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Mobile evidence-based aphasia therapy
Conventional aphasia rehabilitation
Sponsored by
About this trial
This is an interventional treatment trial for Aphasia, Broca
Eligibility Criteria
Inclusion Criteria:
- Patients with any type of aphasia
- 6 or more months have passed since the stroke (chronic stage)
- Age between 18 and 90 years
Exclusion Criteria:
- Non-compliance with some of the inclusion criteria
- Presence of major perceptual, cognitive, motor, cognitive or neuropsychological pathology that can interfere with aphasia or make it difficult to interact with the system, including severe forms of motor impairments and apraxia, visual processing deficits, planning deficits, learning deficits, memory deficits, or attentional deficits
- Inability to understand the study participation
- Patients with an Android phone or tablet
Sites / Locations
- Institute for Bioengineering of Catalonia - Specs Lab
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Experimental Group
Control Group
Arm Description
Mobile evidence-based aphasia therapy
Conventional aphasia therapy
Outcomes
Primary Outcome Measures
Within-group changes of language function
Clinical scale for language (Barcelona Test) will be assessed at baseline T0 (prior to the use of the application) and T1 (after two weeks of use) for the experimental group.
Scale from 0 (minimum) to 365 (maximum) where higher scores indicate a better outcome.
Within-group changes of communication
Clinical scale for communication (Communicative Activity Log; Pulvermüller et al., 2001b) will be assessed at baseline T0 (prior to the use of the application) and T1 (after two weeks of use) for the experimental group.
Scale from 0 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Secondary Outcome Measures
Between-group change of language function
Clinical scale for language (Barcelona Test) will be assessed at baseline T0 (time 0) and T1 (time 1).
Scale from 0 (minimum) to 365 (maximum) where higher scores indicate a better outcome.
Between-group change of communication
Clinical scale for communication (Communicative Activity Log; Pulvermüller et al., 2001b) will be assessed at baseline T0 (time 0) and T1 (time 1).
Scale from 0 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Validation of usability of the technologies used
System Usability Scale (SUS) will be used as a measure of usability of the application.
Scale from 1 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Validation of usability, acceptability, and usefulness of the technologies used
mHealth App Usability Questionnaire (MAUQ) (Zhou, Bao, Setiawan, Saptono, & Parmanto, 2019) will be used as a measure of usability, acceptability, and usefulness of the application.
Scale from 1 (minimum) to 7 (maximum), where higher scores indicate a better outcome.
Amount and time of use
Relationship between the total use of the application, measured in number of sessions and total time spent in minutes using the app, and improvement on the Barcelona test measured on scale from 0-365, where higher scores indicate a better outcome.
Cues used per practice session
Count of cues used by the subjects during the primary sessions of use of the application and compared to the final sessions of use of the application.
Reaction time on tasks in the application
Reaction time, measured in seconds, during the primary sessions of use of the application and compared to the final sessions of use of the application.
Subjects' own validation score of voice recordings
The validation score recorded from the application during the primary sessions of use of the application and compared to the final sessions of use of the application. Measured between 0 and 1 and represents the subject's score of how well they performed the task and recording.
Risk assessment
A custom questionnaire will be used to measure any risks associated with the use of the application.
Full Information
NCT ID
NCT05274360
First Posted
November 16, 2021
Last Updated
March 1, 2022
Sponsor
Institute for Bioengineering of Catalonia
Collaborators
Hospital Universitari Joan XXIII de Tarragona., Universitat Pompeu Fabra
1. Study Identification
Unique Protocol Identification Number
NCT05274360
Brief Title
Remote Neurobased Approach to Aphasia Therapy
Acronym
RNAAT
Official Title
Neuroscience-Based Aphasia Therapy Adapted to Remote, Mobile-Based Treatment
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
November 29, 2021 (Actual)
Primary Completion Date
December 16, 2021 (Actual)
Study Completion Date
December 29, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute for Bioengineering of Catalonia
Collaborators
Hospital Universitari Joan XXIII de Tarragona., Universitat Pompeu Fabra
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is the development and validation of an evidence-based mobile application, based on the core premises of Intensive Language-Action Therapy (ILAT) for aphasia, for the training and improvement of chronic aphasia patients administered at the patient's home. It aims at testing the beneficial effect on the linguistic performance (as assessed by the Barcelona and CAL clinical tests) counteracting learned non-use and the usability of the application as a tool for training once discharged from hospital care.
Detailed Description
Acquired brain lesions such as stroke often result in the most common disabling neurological damages. Up to 42% of stroke patients suffer serious language deficits and patients are frequently left with chronic disabilities which adversely impact their quality of life. One of the main challenges in aphasia rehabilitation includes long-term effects. After a certain time (i.e., 3-6mo, chronic phase), the frequency of therapy will decrease or stop, even if the patient has not always reached the expected or desired level of recovery. After this, a body of evidence suggests that the person with aphasia might decrease the use of verbal language given the negative reinforcement when trying to use the deteriorated function and failing to achieve a successful communication. This might lead to relying on other forms of communication (e.g., gestures) and to a vicious cycle of deterioration of verbal skills known as Learned Non-Use principle. Together with the pandemic socioeconomic situation and limited resources at healthcare facilities, this calls for the need of effective and efficient interventions that can be deployed at the house of the patients, in the form of auto-administered therapy. Despite the limited exploration of portable technologies in aphasia recovery, their use has been extensive and successful in other domains such as motor rehabilitation. Importantly, patients with aphasia report that the number 1 topic they would like to know more about is how to keep recovering after therapy ends.
Following recent evidence on experience-dependent plasticity mechanisms for successful stroke recovery and well-established theory-grounded interventions, such as ILAT, the present study aims to study the usability and improvement potential of a mobile-based aphasia rehabilitation app for stroke patients, used at home. A previous collaboration between both centers (SPECS lab and Hospital Joan XIII) used a computer-based setup. In this study by Grechuta et al. (2019), the Rehabilitation Gaming System for aphasia (RGSa) shows positive significant results on language (P= 0.001) and communication (P<0.05) compared to conventional therapy in the long term (16 weeks). This study will assess the usability, risks, and clinical outcome of the same principles applied to a mobile application that is prescribed to be used at home for two twenty-minutes session per day during two weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aphasia, Broca, Aphasia, Wernicke, Aphasia, Fluent, Aphasia, Nonfluent, Aphasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are assigned to either an experimental group or a control group. In the experimental group the participants will receive mobile-based aphasia therapy for two weeks. In the control group participants will receive no additional therapy apart from the conventional aphasia therapy that they are already receiving.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
Mobile evidence-based aphasia therapy
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Conventional aphasia therapy
Intervention Type
Behavioral
Intervention Name(s)
Mobile evidence-based aphasia therapy
Intervention Description
Use of mobile application to practice language for 2 weeks with a recommendation of 2 sessions per day of 20 minutes. The Android application, which is a Unity-based 2D game, will be installed on the patient's own phone, and they will play individually with the support of a family member if needed. The patients are free to start and stop using the application at any time. The application is safe to use, and it consists of therapeutic training methods such as object-matching, word search, writing, and manual voice recordings.
Intervention Type
Behavioral
Intervention Name(s)
Conventional aphasia rehabilitation
Intervention Description
Control Group (conventional aphasia rehabilitation). No therapy as patients are in the chronic stage, where they do not receive healthcare rehabilitation training.
Primary Outcome Measure Information:
Title
Within-group changes of language function
Description
Clinical scale for language (Barcelona Test) will be assessed at baseline T0 (prior to the use of the application) and T1 (after two weeks of use) for the experimental group.
Scale from 0 (minimum) to 365 (maximum) where higher scores indicate a better outcome.
Time Frame
This will be assessed one day before starting the treatment and at the end of the treatment protocol (after two weeks)
Title
Within-group changes of communication
Description
Clinical scale for communication (Communicative Activity Log; Pulvermüller et al., 2001b) will be assessed at baseline T0 (prior to the use of the application) and T1 (after two weeks of use) for the experimental group.
Scale from 0 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Time Frame
This will be assessed one day before starting the treatment and at the end of the treatment protocol (after two weeks)
Secondary Outcome Measure Information:
Title
Between-group change of language function
Description
Clinical scale for language (Barcelona Test) will be assessed at baseline T0 (time 0) and T1 (time 1).
Scale from 0 (minimum) to 365 (maximum) where higher scores indicate a better outcome.
Time Frame
This will be assessed one day before starting the treatment and at the end of the treatment protocol (after two weeks)
Title
Between-group change of communication
Description
Clinical scale for communication (Communicative Activity Log; Pulvermüller et al., 2001b) will be assessed at baseline T0 (time 0) and T1 (time 1).
Scale from 0 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Time Frame
This will be assessed one day before starting the treatment and at the end of the treatment protocol (after two weeks)
Title
Validation of usability of the technologies used
Description
System Usability Scale (SUS) will be used as a measure of usability of the application.
Scale from 1 (minimum) to 5 (maximum) where higher scores indicate a better outcome.
Time Frame
This will be assessed at the end of the treatment protocol (after two weeks) for the experimental group.
Title
Validation of usability, acceptability, and usefulness of the technologies used
Description
mHealth App Usability Questionnaire (MAUQ) (Zhou, Bao, Setiawan, Saptono, & Parmanto, 2019) will be used as a measure of usability, acceptability, and usefulness of the application.
Scale from 1 (minimum) to 7 (maximum), where higher scores indicate a better outcome.
Time Frame
This will be assessed at the end of the treatment protocol (after two weeks) for the experimental group.
Title
Amount and time of use
Description
Relationship between the total use of the application, measured in number of sessions and total time spent in minutes using the app, and improvement on the Barcelona test measured on scale from 0-365, where higher scores indicate a better outcome.
Time Frame
This will be measured continuously through the use of the application during the two weeks of use.
Title
Cues used per practice session
Description
Count of cues used by the subjects during the primary sessions of use of the application and compared to the final sessions of use of the application.
Time Frame
This will be measured continuously through the use of the application during the two weeks of use.
Title
Reaction time on tasks in the application
Description
Reaction time, measured in seconds, during the primary sessions of use of the application and compared to the final sessions of use of the application.
Time Frame
This will be measured continuously through the use of the application during the two weeks of use.
Title
Subjects' own validation score of voice recordings
Description
The validation score recorded from the application during the primary sessions of use of the application and compared to the final sessions of use of the application. Measured between 0 and 1 and represents the subject's score of how well they performed the task and recording.
Time Frame
This will be measured continuously through the use of the application during the two weeks of use.
Title
Risk assessment
Description
A custom questionnaire will be used to measure any risks associated with the use of the application.
Time Frame
This will be assessed at the end of the treatment protocol (after two weeks) for the experimental group.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with any type of aphasia
6 or more months have passed since the stroke (chronic stage)
Age between 18 and 90 years
Exclusion Criteria:
Non-compliance with some of the inclusion criteria
Presence of major perceptual, cognitive, motor, cognitive or neuropsychological pathology that can interfere with aphasia or make it difficult to interact with the system, including severe forms of motor impairments and apraxia, visual processing deficits, planning deficits, learning deficits, memory deficits, or attentional deficits
Inability to understand the study participation
Patients with an Android phone or tablet
Facility Information:
Facility Name
Institute for Bioengineering of Catalonia - Specs Lab
City
Barcelona
ZIP/Postal Code
08930
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31011013
Citation
Ameer K, Ali K. iPad Use in Stroke Neuro-Rehabilitation. Geriatrics (Basel). 2017 Jan 6;2(1):2. doi: 10.3390/geriatrics2010002.
Results Reference
background
PubMed Identifier
17981847
Citation
Bakheit AM, Shaw S, Barrett L, Wood J, Carrington S, Griffiths S, Searle K, Koutsi F. A prospective, randomized, parallel group, controlled study of the effect of intensity of speech and language therapy on early recovery from poststroke aphasia. Clin Rehabil. 2007 Oct;21(10):885-94. doi: 10.1177/0269215507078486.
Results Reference
background
Citation
Brandenburg, C., & Power, E. (2019). Mobile Technology in Aphasia Rehabilitation: Current Trends and Lessons Learnt. Everyday Technologies in Healthcare, 293-317. https://doi.org/10.1201/9781351032186-16
Results Reference
background
PubMed Identifier
16690899
Citation
Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, Gutzwiller F, Lyrer PA. Epidemiology of aphasia attributable to first ischemic stroke: incidence, severity, fluency, etiology, and thrombolysis. Stroke. 2006 Jun;37(6):1379-84. doi: 10.1161/01.STR.0000221815.64093.8c. Epub 2006 May 11.
Results Reference
background
PubMed Identifier
30913976
Citation
Grechuta K, Rubio Ballester B, Espin Munne R, Usabiaga Bernal T, Molina Hervas B, Mohr B, Pulvermuller F, San Segundo R, Verschure P. Augmented Dyadic Therapy Boosts Recovery of Language Function in Patients With Nonfluent Aphasia. Stroke. 2019 May;50(5):1270-1274. doi: 10.1161/STROKEAHA.118.023729.
Results Reference
background
PubMed Identifier
32907594
Citation
Grechuta K, Rubio Ballester B, Espin Munne R, Usabiaga Bernal T, Molina Hervas B, Mohr B, Pulvermuller F, San Segundo RM, Verschure PFMJ. Multisensory cueing facilitates naming in aphasia. J Neuroeng Rehabil. 2020 Sep 9;17(1):122. doi: 10.1186/s12984-020-00751-w.
Results Reference
background
Citation
Griffith, J. (2018). Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology, 2-4. https://doi.org/10.1007/978-3-319-56782-2
Results Reference
background
Citation
Hallowell, B., & Chapey, R. (2012). Introduction to language intervention strategies in adult aphasia. Language Intervention Strategies in Aphasia and Related Neurogenic Communication Disorders: Fifth Edition, (November), 3-19.
Results Reference
background
PubMed Identifier
22761551
Citation
Hidaka Y, Han CE, Wolf SL, Winstein CJ, Schweighofer N. Use it and improve it or lose it: interactions between arm function and use in humans post-stroke. PLoS Comput Biol. 2012 Feb;8(2):e1002343. doi: 10.1371/journal.pcbi.1002343. Epub 2012 Feb 16.
Results Reference
background
PubMed Identifier
22119074
Citation
Hilari K, Needle JJ, Harrison KL. What are the important factors in health-related quality of life for people with aphasia? A systematic review. Arch Phys Med Rehabil. 2012 Jan;93(1 Suppl):S86-95. doi: 10.1016/j.apmr.2011.05.028. Epub 2011 Nov 25.
Results Reference
background
PubMed Identifier
23695907
Citation
Hinckley JJ, Hasselkus A, Ganzfried E. What people living with aphasia think about the availability of aphasia resources. Am J Speech Lang Pathol. 2013 May;22(2):S310-7. doi: 10.1044/1058-0360(2013/12-0090).
Results Reference
background
PubMed Identifier
33703971
Citation
Hirsch T, Barthel M, Aarts P, Chen YA, Freivogel S, Johnson MJ, Jones TA, Jongsma MLA, Maier M, Punt D, Sterr A, Wolf SL, Heise KF. A First Step Toward the Operationalization of the Learned Non-Use Phenomenon: A Delphi Study. Neurorehabil Neural Repair. 2021 May;35(5):383-392. doi: 10.1177/1545968321999064. Epub 2021 Mar 11.
Results Reference
background
PubMed Identifier
28713191
Citation
Holland A, Fromm D, Forbes M, MacWhinney B. Long-term Recovery in Stroke Accompanied by Aphasia: A Reconsideration. Aphasiology. 2017;31(2):152-165. doi: 10.1080/02687038.2016.1184221. Epub 2016 May 27.
Results Reference
background
PubMed Identifier
32146867
Citation
Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell PM, Feigin V, Norrving B, Owolabi M, Pandian J, Liu L, Cadilhac DA, Thrift AG. Global Stroke Statistics 2019. Int J Stroke. 2020 Oct;15(8):819-838. doi: 10.1177/1747493020909545. Epub 2020 Mar 9.
Results Reference
background
PubMed Identifier
31744553
Citation
Maceira-Elvira P, Popa T, Schmid AC, Hummel FC. Wearable technology in stroke rehabilitation: towards improved diagnosis and treatment of upper-limb motor impairment. J Neuroeng Rehabil. 2019 Nov 19;16(1):142. doi: 10.1186/s12984-019-0612-y.
Results Reference
background
PubMed Identifier
31920570
Citation
Maier M, Ballester BR, Verschure PFMJ. Principles of Neurorehabilitation After Stroke Based on Motor Learning and Brain Plasticity Mechanisms. Front Syst Neurosci. 2019 Dec 17;13:74. doi: 10.3389/fnsys.2019.00074. eCollection 2019.
Results Reference
background
PubMed Identifier
10381238
Citation
Mayo NE, Wood-Dauphinee S, Ahmed S, Gordon C, Higgins J, McEwen S, Salbach N. Disablement following stroke. Disabil Rehabil. 1999 May-Jun;21(5-6):258-68. doi: 10.1080/096382899297684.
Results Reference
background
Citation
Moffatt, K., Pourshahid, G., & Baecker, R. M. (2017). Augmentative and alternative communication devices for aphasia: the emerging role of "smart" mobile devices. Universal Access in the Information Society, 16(1), 115-128. https://doi.org/10.1007/s10209-015-0428-x
Results Reference
background
PubMed Identifier
24033650
Citation
Palmer R, Enderby P, Paterson G. Using computers to enable self-management of aphasia therapy exercises for word finding: the patient and carer perspective. Int J Lang Commun Disord. 2013 Sep-Oct;48(5):508-21. doi: 10.1111/1460-6984.12024. Epub 2013 Jun 18.
Results Reference
background
PubMed Identifier
15959465
Citation
Pulvermuller F. Brain mechanisms linking language and action. Nat Rev Neurosci. 2005 Jul;6(7):576-82. doi: 10.1038/nrn1706.
Results Reference
background
PubMed Identifier
18923644
Citation
Pulvermuller F, Berthier ML. Aphasia therapy on a neuroscience basis. Aphasiology. 2008 Jun;22(6):563-599. doi: 10.1080/02687030701612213. Epub 2008 May 21.
Results Reference
background
PubMed Identifier
11441210
Citation
Pulvermuller F, Neininger B, Elbert T, Mohr B, Rockstroh B, Koebbel P, Taub E. Constraint-induced therapy of chronic aphasia after stroke. Stroke. 2001 Jul;32(7):1621-6. doi: 10.1161/01.str.32.7.1621.
Results Reference
background
PubMed Identifier
27842269
Citation
Stahl B, Mohr B, Dreyer FR, Lucchese G, Pulvermuller F. Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia. Cortex. 2016 Dec;85:90-99. doi: 10.1016/j.cortex.2016.09.021. Epub 2016 Oct 15.
Results Reference
background
PubMed Identifier
24904925
Citation
Tippett DC, Niparko JK, Hillis AE. Aphasia: Current Concepts in Theory and Practice. J Neurol Transl Neurosci. 2014 Jan;2(1):1042.
Results Reference
background
PubMed Identifier
23127795
Citation
Vallila-Rohter S, Kiran S. Non-linguistic learning and aphasia: evidence from a paired associate and feedback-based task. Neuropsychologia. 2013 Jan;51(1):79-90. doi: 10.1016/j.neuropsychologia.2012.10.024. Epub 2012 Nov 2.
Results Reference
background
PubMed Identifier
30973342
Citation
Zhou L, Bao J, Setiawan IMA, Saptono A, Parmanto B. The mHealth App Usability Questionnaire (MAUQ): Development and Validation Study. JMIR Mhealth Uhealth. 2019 Apr 11;7(4):e11500. doi: 10.2196/11500.
Results Reference
background
Learn more about this trial
Remote Neurobased Approach to Aphasia Therapy
We'll reach out to this number within 24 hrs